Biblio Discovery — Demo Discovery Service

4 hasil untuk "Feng Bi"

Menampilkan 1–4 · 0,24 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer

    Gongmin Zhu; Lijiao Pei; Hongwei Xia dkk.

    Molecular Cancer · 2021 · Inggris · OpenAlex Scopus

    Abstract Colorectal cancer (CRC) is a heterogeneous disease at the cellular and molecular levels. Kirsten rat sarcoma ( KRAS ) is a commonly mutated oncogene in CRC, with mutations in approximately 40% of all CRC cases; its mutations result in constitutive activation of the KRAS protein, which acts…

  2. Artikel Jurnal Teks lengkap

    Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

    Shukui Qin; Feng Bi; Shanzhi Gu dkk.

    Journal of Clinical Oncology · 2021 · Inggris · OpenAlex Scopus

    PURPOSE Donafenib, a novel multikinase inhibitor and a deuterated sorafenib derivative, has shown efficacy in phase Ia and Ib hepatocellular carcinoma (HCC) studies. This study compared the efficacy and safety of donafenib versus sorafenib as first-line therapy for advanced HCC. PATIENTS AND…

  3. Artikel Jurnal Teks lengkap

    The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

    Feng‐Hua Wang; Xiao‐Tian Zhang; Yuanfang Li dkk.

    癌症:英文版 · 2021 · Inggris · OpenAlex

    Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. The Chinese Society of Clinical Oncology (CSCO)…

  4. Artikel Jurnal Teks lengkap

    The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

    Feng‐Hua Wang; Xiao‐Tian Zhang; Lei Tang dkk.

    癌症:英文版 · 2023 · Inggris · OpenAlex

    The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence-based medicine, healthcare resource availability, and precision medicine. These…